Budigalimab (Anti-PDCD1 / PD-1 / CD279)

Budigalimab (Anti-PDCD1 / PD-1 / CD279) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. It can be used in the treatment of advanced solid tumors. MW :145.84 KD.

• Supplier: Selleck Chemicals
• Product #: A3028
• Sku #: A3028-1mg*25